FDA's commitment to transparency : vimarsana.com

© Getty Images
Transparency in the decisions that the FDA makes in its scientific review of drugs and biologics is an important element of FDA’s mission to protect the public health, particularly as we announce the agency’s decisions on COVID-19 vaccine submissions. As the research and development of vaccines and treatments for COVID-19 continue, I want to reaffirm the commitment of the FDA to transparency. We will publicly share information on FDA’s decisions, especially around Emergency Use Authorizations (EUAs), to promote public confidence in the FDA’s scientific review process and the appropriate use of the authorized products.

Related Keywords

United States , , Pfizer , Oncology Center , Human Services , Products Advisory Committee , Emergency Use Authorizations , Related Biological Products Advisory Committee , Preparedness Plan , Excellence Real Time Oncology Review , Project Orbis , ஒன்றுபட்டது மாநிலங்களில் , ஃபைசர் , புற்றுநோயியல் மையம் , மனிதன் சேவைகள் , ப்ரிப்யாரெட்நெஸ் திட்டம் , சிறப்பானது ரியல் நேரம் புற்றுநோயியல் விமர்சனம் , ப்ராஜெக்ட் ஆர்‌பிஸ் ,